SEC Comment Letter for AIM ImmunoTech Inc. (AIM) (CIK 0000946644) (AIM) — Feb 22, 2011
AIM ImmunoTech Inc. (AIM) (CIK 0000946644)
Date: Feb. 22, 2011 · CIK: 0000946644 · Accession: 0000000000-11-011309
AI Filing Summary & Sentiment
Reasoning
Letter
February 15. 2011 William A. Carter, M.D. Chief Executive Officer Hemispherx Biopharma, Inc. 1617 JFK Boulevard Philadelphia, PA 19103 Re: Hemispherx Biopharma, Inc. Form 10-K for the year ended December 31, 2009 Form 10-K/A for the year ended December 31, 2009 File No. 1-13441
Dear Mr. Carter: We have completed our review of your Form 10-K and related filings and have no further comments at this time. S i n c e r e l y , G u s R o d r i g u e z A c c o u n t i n g B r a n c h C h i e f
Show Raw Text
February 15. 2011 William A. Carter, M.D. Chief Executive Officer Hemispherx Biopharma, Inc. 1617 JFK Boulevard Philadelphia, PA 19103 Re: Hemispherx Biopharma, Inc. Form 10-K for the year ended December 31, 2009 Form 10-K/A for the year ended December 31, 2009 File No. 1-13441 Dear Mr. Carter: We have completed our review of your Form 10-K and related filings and have no further comments at this time. S i n c e r e l y , G u s R o d r i g u e z A c c o u n t i n g B r a n c h C h i e f